Financhill
Sell
35

MTH Quote, Financials, Valuation and Earnings

Last price:
$65.58
Seasonality move :
5.64%
Day range:
$64.35 - $66.30
52-week range:
$59.27 - $106.99
Dividend yield:
2.42%
P/E ratio:
6.51x
P/S ratio:
0.75x
P/B ratio:
0.89x
Volume:
781.4K
Avg. volume:
856.8K
1-year change:
-27.5%
Market cap:
$4.6B
Revenue:
$6.4B
EPS (TTM):
$9.88

Earnings Data

Next earnings date for MTH
Jul 24
2025
Most recent earnings per share
$1.69
Beat by $0.01
(Apr 23/2025)
Consensus Estimate
$1.68
(Apr 23/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MTH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/24/2025 Q2 $1.6B -- -- $2.00 --
04/23/2025 Q1 $1.3B $1.4B $1.69 $1.68 $0.01
01/29/2025 Q4 $1.6B $1.6B $2.36 $2.20 $0.16
10/29/2024 Q3 $1.6B $1.6B $2.67 $2.49 $0.18
07/24/2024 Q2 $1.6B $1.7B $3.16 $2.58 $0.58
04/24/2024 Q1 $1.3B $1.5B $2.53 $1.76 $0.77
01/31/2024 Q4 $1.5B $1.7B $2.69 $2.59 $0.10
10/31/2023 Q3 $1.6B $1.6B $2.99 $2.56 $0.43
07/27/2023 Q2 $1.3B $1.6B $2.51 $1.75 $0.76
04/26/2023 Q1 -- $1.3B $1.77 -- --
02/01/2023 Q4 -- $2B $3.55 -- --
10/26/2022 Q3 -- $1.6B $3.55 -- --
07/27/2022 Q2 -- $1.4B $3.39 -- --
04/27/2022 Q1 -- $1.3B $2.90 -- --
01/26/2022 Q4 -- $1.5B $3.13 -- --
10/27/2021 Q3 -- $1.3B $2.63 -- --
07/28/2021 Q2 -- $1.3B $2.18 -- --
04/28/2021 Q1 -- $1.1B $1.72 -- --
01/27/2021 Q4 -- $1.4B $1.99 -- --
10/21/2020 Q3 -- $1.1B $1.42 -- --
07/22/2020 Q2 -- $1B $1.19 -- --
04/29/2020 Q1 -- $905.6M $0.92 -- --
01/29/2020 Q4 -- $1.1B $1.33 -- --
10/22/2019 Q3 -- $948.2M $0.90 -- --
07/24/2019 Q2 -- $872.4M $0.66 -- --
04/23/2019 Q1 -- $714.4M $0.33 -- --
01/30/2019 Q4 -- $1B $0.96 -- --
10/24/2018 Q3 -- $892.6M $0.67 -- --
07/25/2018 Q2 -- $884.8M $0.66 -- --
04/25/2018 Q1 -- $748.3M $0.54 -- --
02/01/2018 Q4 -- $954.7M $0.44 -- --
10/27/2017 Q3 -- $812.6M $0.51 -- --
08/01/2017 Q2 -- $809.1M $0.49 -- --
04/27/2017 Q1 -- $678.4M $0.28 -- --
02/01/2017 Q4 -- $888.3M $0.61 -- --
10/27/2016 Q3 -- $760.2M $0.44 -- --
07/28/2016 Q2 -- $805.2M $0.48 -- --
04/28/2016 Q1 -- $603.1M $0.25 -- --
01/28/2016 Q4 -- $788.7M $0.63 -- --
10/29/2015 Q3 -- $676.8M $0.37 -- --
07/29/2015 Q2 -- $603.3M $0.35 -- --

Meritage Homes Earnings Questions

  • How Much did Meritage Homes Generate in Revenue Last Quarter?

    Meritage Homes reported $1.4B worth of top line sales in its most recent quarter.

  • Did Meritage Homes Beat Earnings Last Quarter?

    Meritage Homes announced earnings per share of $1.69 which represents a beat of analyst forecast a $1.68 per share.

  • Is Meritage Homes Profitable?

    Meritage Homes reported $302.4M that represents $4.16 per share over the last quarter.

  • What is the Analyst Consensus for Meritage Homes EPS Next Year?

    Meritage Homes's earnings are forecast to decrease from $10.72 per share to $10.60 per share next year representing a decrease of -22.51%.

  • When is Meritage Homes's Earnings Date?

    Meritage Homes's next earnings date is July 24, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is It Time to Sell MercadoLibre?
Is It Time to Sell MercadoLibre?

MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…

Is Tesla Stock High Risk or High Reward?
Is Tesla Stock High Risk or High Reward?

EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…

Why Did Chase Coleman Buy TSM?
Why Did Chase Coleman Buy TSM?

Billionaire Chase Coleman of Tiger Global Management has built a…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 48x

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
52
CTRN alert for Jun 5

Citi Trends [CTRN] is up 2.77% over the past day.

Sell
44
RGC alert for Jun 4

Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.

Buy
63
MLTX alert for Jun 4

MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock